Orthovita, Inc (VITA)

Orthovita, Inc. engages in the development and commercialization of synthetic, biologically active tissue engineering products for orthopedic and neurosurgical applications. Its products include VITOSS bone graft substitute; IMBIBE Bone marrow aspirate syringes; VITAGEL surgical hemostat; CORTOSS synthetic cortical bone; ALIQUOT micro delivery system; and ENDOSKELETON TA and structural devices. VITOSS Bone Graft Substitute is an ultra-porous resorbable beta-tricalcium phosphate bone void filler used in helping the body guide the three-dimensional regeneration of the patient’s own bone. IMBIBE Bone marrow aspirate syringe device provides spine and orthopedic surgeons...